Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ambrx Biopharma, Inc. | Chief Financial Officer | Common Stock | 0 | $0 | $9.82 | Mar 7, 2024 | Direct |
Ambrx Biopharma, Inc. | Chief Financial Officer | Restricted Stock Units | 0 | $0 | $9.82 | Mar 7, 2024 | Direct |
Ambrx Biopharma Inc. | Chief Financial Officer | Stock Option (right to buy) | 389K | Jul 5, 2023 | Direct | ||
Motus GI Holdings, Inc. | Director | Stock Option (right to buy) | 23.2K | Mar 5, 2024 | Direct | ||
Ambrx Biopharma, Inc. | Chief Financial Officer | Option to Purchase Common Stock | 0 | Mar 7, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AMAM | Ambrx Biopharma, Inc. | Mar 7, 2024 | 7 | $0 | 4 | Mar 7, 2024 | Chief Financial Officer |
MOTS | Motus GI Holdings, Inc. | Mar 5, 2024 | 1 | $0 | 4 | Mar 13, 2024 | Director |
AMAM | Ambrx Biopharma, Inc. | Dec 11, 2023 | 1 | $0 | 4 | Dec 11, 2023 | Chief Financial Officer |
AMAM | Ambrx Biopharma, Inc. | Oct 27, 2023 | 1 | -$125K | 4 | Oct 31, 2023 | Chief Financial Officer |
AMAM | Ambrx Biopharma Inc. | Jul 5, 2023 | 1 | $0 | 4 | Jul 7, 2023 | Chief Financial Officer |
AMAM | Ambrx Biopharma Inc. | Apr 26, 2023 | 1 | $0 | 4 | Apr 28, 2023 | Chief Fin. & Operating Officer |
AMAM | Ambrx Biopharma Inc. | Jan 27, 2023 | 6 | $0 | 4 | Jan 31, 2023 | Chief Fin. & Operating Officer |
AMAM | Ambrx Biopharma Inc. | Jan 1, 2023 | 0 | $0 | 3 | Jan 3, 2023 | Chief Fin. & Operating Officer |
MOTS | Motus GI Holdings, Inc. | Feb 10, 2022 | 1 | $0 | 4 | Feb 11, 2022 | Director |
MOTS | Motus GI Holdings, Inc. | Jan 5, 2022 | 1 | $0 | 4 | Jan 7, 2022 | Director |
MOTS | Motus GI Holdings, Inc. | Jun 22, 2021 | 2 | $0 | 4 | Jun 23, 2021 | Director |
MOTS | Motus GI Holdings, Inc. | Jun 22, 2021 | 0 | $0 | 3 | Jun 23, 2021 | Director |